Growing Population of Americans Living with Type 1 Diabetes Highlights Need to Accelerate Life-Saving Cell Therapy Cures for the Disease NEW YORK, May 13, 2025 /PRNewswire/ -- Breakthrough T1D ...

Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are ...

Islet transplantation offered significant benefits in reducing mortality and other complications in patients with type 1 diabetes (T1D) over a median follow-up duration exceeding 10 years.

We are just about a month away from a classic Capital Region Walk -- the Breakthrough T1D walk in Clifton Park. Breakthrough T1D is the leading Type 1 Diabetes research and advocacy organization ...

Founded in 1970 by families whose loved ones had been diagnosed with type 1 diabetes (T1D), Breakthrough T1D, formerly JDRF, is a tax-exempt nonprofit 501(c)3 organization, opening doors that ...